QIAGEN to Transfer U.S. Listing of Global Shares to NYSE

December 8, 2017 |

1 min read

QIAGEN N.V. today announced that it is transferring the U.S. listing of its global shares to the NYSE from the NASDAQ Global Market.

[08-December-2017]

GERMANTOWN, Maryland, and HILDEN, Germany, December 8, 2017 /PRNewswire/ --

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that it is transferring the U.S. listing of its global shares to the New York Stock Exchange (NYSE) from the NASDAQ Global Market.

Click here [https://corporate.qiagen.com/newsroom/press-releases/2017/2017-12-08_NYSE_listing?sc_lang=en ] for the full press release https://corporate.qiagen.com/newsroom/press-releases/2017/2017-12-08_NYSE_listing?sc_lang= en [https://corporate.qiagen.com/newsroom/press-releases/2017/%202017-12-08_NYSE_listing?sc_lang=en ]

Contacts:

QIAGEN

            Investor Relations 
        John Gilardi 
        +49-21-032-911-711 
        e-mail: ir@QIAGEN.com 


        Public Relations 
        Dr. Thomas Theuringer 
        +49-21-032-911-826  
        e-mail: pr@QIAGEN.com

SOURCE Qiagen N.V.

Company Codes: Frankfurt:QIA, NASDAQ-NMS:QGEN, Bloomberg:QGEN@US, Bloomberg:QIA@GR, RICS:QGEN.F, ISIN:NL0000240000

Diagnostics Europe